BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 31740319)

  • 21. Methods and guidance on conducting, reporting, publishing, and appraising living systematic reviews: a scoping review.
    Iannizzi C; Akl EA; Anslinger E; Weibel S; Kahale LA; Aminat AM; Piechotta V; Skoetz N
    Syst Rev; 2023 Dec; 12(1):238. PubMed ID: 38098023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compliance of systematic reviews in ophthalmology with the PRISMA statement.
    Lee SY; Sagoo H; Farwana R; Whitehurst K; Fowler A; Agha R
    BMC Med Res Methodol; 2017 Dec; 17(1):178. PubMed ID: 29281981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
    Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
    Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research.
    Kapadia MZ; Askie L; Hartling L; Contopoulos-Ioannidis D; Bhutta ZA; Soll R; Moher D; Offringa M
    BMJ Open; 2016 Apr; 6(4):e010270. PubMed ID: 27091820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Introduction to PRISMA-CI extension statement and checklist systematic reviews on complex interventions].
    Zhang G; Wang WW; Yang ZR; Zhan SY; Sun F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jul; 40(7):832-838. PubMed ID: 31357807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reporting quality of systematic reviews with network meta-analyses in Endodontics.
    Nagendrababu V; Narasimhan S; Faggion CM; Dharmarajan L; Jacob PS; Gopinath VK; Dummer PMH
    Clin Oral Investig; 2023 Jul; 27(7):3437-3445. PubMed ID: 36914841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reporting quality of Cochrane systematic reviews with Chinese herbal medicines.
    Zhang X; Aixinjueluo QY; Li SY; Song LL; Lau CT; Tan R; Bian ZX
    Syst Rev; 2019 Dec; 8(1):302. PubMed ID: 31796121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining the Completeness of Registration and Reporting in Systematic Reviews of Yoga for Health.
    Bethel K; Faciszewski H; Ballis S; Sullivan M; Wieland LS
    J Integr Complement Med; 2024 Apr; 30(4):336-344. PubMed ID: 37967461
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of the abstract reporting of systematic reviews of dose-response meta-analysis: a literature survey.
    Jia PL; Xu B; Cheng JM; Huang XH; Kwong JSW; Liu Y; Zhang C; Han Y; Xu C
    BMC Med Res Methodol; 2019 Jul; 19(1):148. PubMed ID: 31307388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Moher D
    J Clin Epidemiol; 2021 Jun; 134():103-112. PubMed ID: 33577987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methodological quality of systematic reviews referenced in clinical practice guidelines for the treatment of opioid use disorder.
    Ross A; Rankin J; Beaman J; Murray K; Sinnett P; Riddle R; Haskins J; Vassar M
    PLoS One; 2017; 12(8):e0181927. PubMed ID: 28771633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating characteristics of PROSPERO records as predictors of eventual publication of non-Cochrane systematic reviews: a meta-epidemiological study protocol.
    Ruano J; Gómez-García F; Gay-Mimbrera J; Aguilar-Luque M; Fernández-Rueda JL; Fernández-Chaichio J; Alcalde-Mellado P; Carmona-Fernandez PJ; Sanz-Cabanillas JL; Viguera-Guerra I; Franco-García F; Cárdenas-Aranzana M; Romero JLH; Gonzalez-Padilla M; Isla-Tejera B; Garcia-Nieto AV
    Syst Rev; 2018 Mar; 7(1):43. PubMed ID: 29523200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Epidemiology in China series. Paper 3: The methodological and reporting quality of systematic reviews and meta-analyses published by China' researchers in English-language is higher than those published in Chinese-language.
    Cao L; Yao L; Hui X; Li J; Zhang X; Li M; Feng Z; Ren M; Xian K; Sun Y; Liu Y; Luo X; Chen Y; Yang K
    J Clin Epidemiol; 2021 Dec; 140():178-188. PubMed ID: 34418547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, quality, and reporting characteristics of systematic reviews and meta-analyses of nursing interventions published in Chinese journals.
    Zhang J; Wang J; Han L; Zhang F; Cao J; Ma Y
    Nurs Outlook; 2015; 63(4):446-455.e4. PubMed ID: 26187084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compliance With Preferred Reporting Items for Systematic Review and Meta-Analysis Individual Participant Data Statement for Meta-Analyses Published for Stroke Studies.
    Jumah F; Chotai S; Ashraf O; Rallo MS; Raju B; Gadhiya A; Sun H; Narayan V; Gupta G; Nanda A
    Stroke; 2021 Aug; 52(9):2817-2826. PubMed ID: 34082573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRISMA 2020 statement: What's new and the importance of reporting guidelines.
    Sohrabi C; Franchi T; Mathew G; Kerwan A; Nicola M; Griffin M; Agha M; Agha R
    Int J Surg; 2021 Apr; 88():105918. PubMed ID: 33789825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology, methodological quality, and reporting characteristics of systematic reviews and meta-analyses on coronavirus disease 2019: A cross-sectional study.
    Chen Y; Li L; Zhang Q; Liu H; Huang Y; Lin S; Yin G; Xie Q
    Medicine (Baltimore); 2021 Nov; 100(47):e27950. PubMed ID: 34964777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.